// App-Quantinova.ai

OP036 : Five-year follow-up of safety and efficacy of the Resolute zotarolimus-eluting stent: insights from the RESOLUTE global clinical trial program in approximately 8,000 patients

Researchers

Presenter

  • Silber S

Principal Investigators

  • N/A

Medical Centers

  • Heart Center at the Isar, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved